NFKB1 and diffuse large B-cell lymphoma: NBD peptide also inhibits constitutive NF-κB activity in malignant cell lines derived from many different cancer types, including ABC-DLBCL resulting in increased sensitization to chemotherapeutic agents and increased apoptosis [21]–[26].